These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 30230033)

  • 1. Amphiregulin enhances cell migration and resistance to doxorubicin in chondrosarcoma cells through the MAPK pathway.
    Chen JC; Huang C; Lee IN; Wu YP; Tang CH
    Mol Carcinog; 2018 Dec; 57(12):1816-1824. PubMed ID: 30230033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Basic fibroblast growth factor promotes doxorubicin resistance in chondrosarcoma cells by affecting XRCC5 expression.
    Hsieh MJ; Huang C; Lin CC; Tang CH; Lin CY; Lee IN; Huang HC; Chen JC
    Mol Carcinog; 2020 Mar; 59(3):293-303. PubMed ID: 31916307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amphiregulin Promotes Vascular Endothelial Growth Factor-C Expression and Lymphangiogenesis through STAT3 Activation in Human Chondrosarcoma Cells.
    Huang YW; Tsai HC; Wang SW; Kuo SJ; Fong YC; Tang CH
    Cell Physiol Biochem; 2019; 52(1):1-15. PubMed ID: 30790501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-631 Resensitizes Doxorubicin-Resistant Chondrosarcoma Cells by Targeting Apelin.
    Chen JC; Shih HC; Lin CY; Guo JH; Huang C; Huang HC; Chong ZY; Tang CH
    Int J Mol Sci; 2023 Jan; 24(1):. PubMed ID: 36614283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amphiregulin enhances alpha6beta1 integrin expression and cell motility in human chondrosarcoma cells through Ras/Raf/MEK/ERK/AP-1 pathway.
    Chen JC; Chen YJ; Lin CY; Fong YC; Hsu CJ; Tsai CH; Su JL; Tang CH
    Oncotarget; 2015 May; 6(13):11434-46. PubMed ID: 25825984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of ethanol on the anticancer function of doxorubicin in JJ012 cells.
    Huang H; Li Y; Wu M; Luo J; Nie J; Hou B; He Q; Diao Y; Qi L; Zhao Y; Liu Y; Yang D; Zhou L
    Future Oncol; 2018 Jun; 14(13):1285-1297. PubMed ID: 29774752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endothelin-1 enhances cell migration through COX-2 up-regulation in human chondrosarcoma.
    Wu MH; Chen LM; Hsu HH; Lin JA; Lin YM; Tsai FJ; Tsai CH; Huang CY; Tang CH
    Biochim Biophys Acta; 2013 Jun; 1830(6):3355-64. PubMed ID: 23523690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glutamine metabolism controls amphiregulin-facilitated chemoresistance to cisplatin in human chondrosarcoma.
    Wu YY; Law YY; Huang YW; Tran NB; Lin CY; Lai CY; Huang YL; Tsai CH; Ko CY; Chou MC; Huang WC; Cheng FJ; Fong YC; Tang CH
    Int J Biol Sci; 2023; 19(16):5174-5186. PubMed ID: 37928274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amphiregulin enhances VEGF-A production in human chondrosarcoma cells and promotes angiogenesis by inhibiting miR-206 via FAK/c-Src/PKCδ pathway.
    Wang CQ; Huang YW; Wang SW; Huang YL; Tsai CH; Zhao YM; Huang BF; Xu GH; Fong YC; Tang CH
    Cancer Lett; 2017 Jan; 385():261-270. PubMed ID: 27826039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional roles of CSPG4/NG2 in chondrosarcoma.
    Jamil NS; Azfer A; Worrell H; Salter DM
    Int J Exp Pathol; 2016 Apr; 97(2):178-86. PubMed ID: 27292772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CTGF enhances migration and MMP-13 up-regulation via alphavbeta3 integrin, FAK, ERK, and NF-kappaB-dependent pathway in human chondrosarcoma cells.
    Tan TW; Lai CH; Huang CY; Yang WH; Chen HT; Hsu HC; Fong YC; Tang CH
    J Cell Biochem; 2009 May; 107(2):345-56. PubMed ID: 19301259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-tumor effects of a nonsteroidal anti-inflammatory drug zaltoprofen on chondrosarcoma via activating peroxisome proliferator-activated receptor gamma and suppressing matrix metalloproteinase-2 expression.
    Higuchi T; Takeuchi A; Munesue S; Yamamoto N; Hayashi K; Kimura H; Miwa S; Inatani H; Shimozaki S; Kato T; Aoki Y; Abe K; Taniguchi Y; Aiba H; Murakami H; Harashima A; Yamamoto Y; Tsuchiya H
    Cancer Med; 2018 May; 7(5):1944-1954. PubMed ID: 29573200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting glucose metabolism in chondrosarcoma cells enhances the sensitivity to doxorubicin through the inhibition of lactate dehydrogenase-A.
    Hua G; Liu Y; Li X; Xu P; Luo Y
    Oncol Rep; 2014 Jun; 31(6):2727-34. PubMed ID: 24789077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The oncogene LRF is a survival factor in chondrosarcoma and contributes to tumor malignancy and drug resistance.
    Kumari R; Li H; Haudenschild DR; Fierro F; Carlson CS; Overn P; Gupta L; Gupta K; Nolta J; Yik JH; Di Cesare PE
    Carcinogenesis; 2012 Nov; 33(11):2076-83. PubMed ID: 22847180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-125b acts as a tumor suppressor in chondrosarcoma cells by the sensitization to doxorubicin through direct targeting the ErbB2-regulated glucose metabolism.
    Tang XY; Zheng W; Ding M; Guo KJ; Yuan F; Feng H; Deng B; Sun W; Hou Y; Gao L
    Drug Des Devel Ther; 2016; 10():571-83. PubMed ID: 26966351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amphiregulin promotes cisplatin chemoresistance by upregulating ABCB1 expression in human chondrosarcoma.
    Huang YW; Lin CY; Tsai HC; Fong YC; Han CK; Huang YL; Wu WT; Cheng SP; Chang HC; Liao KW; Wang SW; Tang CH
    Aging (Albany NY); 2020 May; 12(10):9475-9488. PubMed ID: 32428872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Secreted amphiregulin promotes vincristine resistance in oral squamous cell carcinoma.
    Hsieh MJ; Chen YH; Lee IN; Huang C; Ku YJ; Chen JC
    Int J Oncol; 2019 Oct; 55(4):949-959. PubMed ID: 31485602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. No preclinical rationale for IGF1R directed therapy in chondrosarcoma of bone.
    Peterse EF; Cleven AH; De Jong Y; Briaire-de Bruijn I; Fletcher JA; Danen EH; Cleton-Jansen AM; Bovée JV
    BMC Cancer; 2016 Jul; 16():475. PubMed ID: 27418340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CCN6-mediated MMP-9 activation enhances metastatic potential of human chondrosarcoma.
    Tzeng HE; Tang CH; Wu SH; Chen HT; Fong YC; Lu YC; Chen WC; Huang HD; Lin CY; Wang SW
    Cell Death Dis; 2018 Sep; 9(10):955. PubMed ID: 30237403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PRP‑1 significantly decreases the ALDHhigh cancer stem cell population and regulates the aberrant Wnt/β‑catenin pathway in human chondrosarcoma JJ012 cells.
    Hoyt AK; Moran A; Granger C; Sedani A; Saigh S; Brown J; Galoian KA
    Oncol Rep; 2019 Jul; 42(1):103-114. PubMed ID: 31180539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.